Effectiveness of sacubitril–valsartan in cancer patients with heart failure-Reference-Cited by-同舟云学术

Effectiveness of sacubitril–valsartan in cancer patients with heart failure

Published:2020-02-05 Issue:2 Volume:7 Page:763-767
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Martín‐Garcia Ana¹²,López‐Fernández Teresa²³,Mitroi Cristina⁴,Chaparro‐Muñoz Marinela⁵,Moliner Pedro⁶,Martin‐Garcia Agustin C.¹²,Martinez‐Monzonis Amparo²⁷,Castro Antonio²⁵,Lopez‐Sendon Jose L.²³,Sanchez Pedro L.¹²

Affiliation:

1. Department of Cardiology Hospital Universitario de Salamanca—IBSAL, University of Salamanca Paseo de San Vicente 58‐187 37007 Salamanca Spain

2. CIBERCV Instituto de Salud Carlos III Madrid Spain

3. Department of Cardiology Hospital La Paz—IdiPAZ Madrid Spain

4. Department of Cardiology Hospital Puerta de Hierro—IDIPHISA, Majadahonda Madrid Spain

5. Department of Cardiology Hospital Virgen de la Macarena—IBiS Seville Spain

6. Department of Cardiology Hospital Universitari Germans Trias I Pujol—IGTP, Badalona Barcelona Spain

7. Department of Cardiology Hospital Clínico Universitario de Santiago de Compostela—IDIS Santiago de Compostela, A Coruña Spain

Funder

European Regional Development Fund

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12627

Reference9 articles.

1. Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

2. Response of Doxorubicin-induced Cardiomyopathy to the Current Management Strategy of Heart Failure

3. Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience

4. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

5. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum;European Heart Journal - Digital Health;2024-08-30

2. Cancer and Heart Failure: Dangerous Liaisons;Journal of Cardiovascular Development and Disease;2024-08-27

3. Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα-mTORC1 signaling pathway;2024-07-29

4. Sacubitril/valsartan alleviates sunitinib-induced cardiac fibrosis and oxidative stress via improving TXNIP/TRX system and downregulation of NF-ĸB/Wnt/β-catenin/SOX9 signaling;International Immunopharmacology;2024-05

5. Anthracycline-induced Heart Failure: Treatment and Recovery Prospects;Kardiologiia;2024-04-30